ID
22105
Descripción
The present pharmacokinetic study is designed to assess the pharmacokinetics of RSG XR as monotherapy in patients with mild Alzheimer's disease (AD) as such information will not be obtained from the current phase III trials . The study aims to enroll fourteen patients (seven of each APOE genotype). Each patient will receive a single oral dose of 4mg of RSG XR in the morning under fasted conditions and PK samples will be taken up to 36h. GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1
Palabras clave
Versiones (2)
- 8/5/17 8/5/17 -
- 20/5/17 20/5/17 -
Subido en
20 de mayo de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Follow-up Vital Signs ECG Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR) NCT00688207 / GSK-AVA109941
Follow-up Vital Signs ECG Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR) NCT00688207 / GSK-AVA109941
Descripción
12-Lead ECG
Alias
- UMLS CUI-1
- C0430456
Descripción
ECG Number
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1300638
- UMLS CUI [1,2]
- C0180600
Descripción
Start date of ECG
Tipo de datos
date
Unidades de medida
- Day Month Year
Alias
- UMLS CUI [1,1]
- C0430456
- UMLS CUI [1,2]
- C0808070
Descripción
Planned Relative Time
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0439564
Descripción
Start Time of ECG
Tipo de datos
time
Unidades de medida
- Hr : Min
Alias
- UMLS CUI [1,1]
- C0430456
- UMLS CUI [1,2]
- C1301880
Descripción
Heart Rate
Tipo de datos
float
Unidades de medida
- Beats/min
Alias
- UMLS CUI [1]
- C0018810
Descripción
PR Interval
Tipo de datos
time
Unidades de medida
- msec
Alias
- UMLS CUI [1]
- C0429087
Descripción
QRS Duration
Tipo de datos
time
Unidades de medida
- Hr : Min
Alias
- UMLS CUI [1]
- C0429025
Descripción
Uncorrected QT Interval
Tipo de datos
time
Unidades de medida
- Hr : Min
Alias
- UMLS CUI [1]
- C1287082
Descripción
QTc interval
Tipo de datos
time
Unidades de medida
- Hr : Min
Alias
- UMLS CUI [1]
- C0489625
Descripción
Enter Code for result from following list: 1=Normal 2=Abnormal - not clinically significant* 3=Abnormal - clinically significant 4=No result (not available) *Complete the Non-Serious Adverse Events (AE) or Serious Adverse Event (SAE) page(s) if clinically significant abnormalities meet the protocol definition for an AE or SAE. Complete the additional ECG Abnormalities page if clinically significant abnormalities are present.
Tipo de datos
float
Alias
- UMLS CUI [1]
- C0438154
Similar models
Follow-up Vital Signs ECG Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR) NCT00688207 / GSK-AVA109941
C0011008 (UMLS CUI [1,2])
C2348792 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])